Pre-Market Gappers

Gapping up on strong earnings/guidance: SPEC +12.4%, USBE +6.7%, JASO +6.0%, PMCS +5.9%, RHT +5.4%... DNDN +264.0% after FDA committee voted in favor of Provenge for advanced prostate cancer; "cancer plays" up in sympathy: CEGE +29.1%, AGEN +23.7%, INGN +22.4%, NUVO +11.1%, CYTO +9.5%, VICL +7.4%, MEDX +6.2%, INCY +5.5%... Ethanol stocks trading higher following crop report: AVR +5.5%, XNL +2.1%, PEIX +1.9%... Other news: IMH +10.4% (cuts dividend, securitizes loans), AVII +5.4% (initiated with a Buy and $5 tgt at Maxim), TGEN +4.2% (continued momentum from yesterday's earnings-related spike